Insideraktier | 14 972 175 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Dicerna Pharmaceuticals Inc insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i DRNA / Dicerna Pharmaceuticals Inc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i DRNA / Dicerna Pharmaceuticals Inc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 3,47 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam See footnotes | DRNA | Common Stock | I | 38,2500 | −3 080 237 | −117 819 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Common Stock | D | 38,2500 | −3 333 | −127 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −68 100 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −121 300 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | −75 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 16,30 | −111 800 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | −180 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | −105 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −33 999 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −11 879 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | −11 325 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | −25 950 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Common Stock | D | 38,2500 | −18 100 | −692 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −46 120 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | −81 825 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | −13 669 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | −7 688 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Common Stock | D | 38,2500 | −5 032 | −192 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 3,26 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 18,73 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 16,30 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 13,87 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | D | 38,2500 | −16 157 | −618 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 10,31 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 38,2500 | −5 000 | −191 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Common Stock | D | 38,2500 | −6 333 | −242 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −36 900 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 20,79 | −95 650 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | −6 150 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | −20 475 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 38,2500 | −7 775 | −297 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 14,32 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Common Stock | D | 38,2500 | −3 333 | −127 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Common Stock | D | 38,2500 | −3 333 | −127 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 3,26 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Common Stock | D | 38,2500 | −3 333 | −127 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 15,61 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Common Stock | D | 38,2500 | −3 333 | −127 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −247 700 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −250 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | −225 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −225 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS By Trust | DRNA | Employee Stock Option (Right to Buy) | I | 16,30 | −200 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS By Trust | DRNA | Employee Stock Option (Right to Buy) | I | 16,30 | −200 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 16,30 | −71 900 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | −505 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | −255 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −55 055 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −281 250 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −191 330 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | −41 250 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | −59 850 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 38,2500 | −231 431 | −8 852 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −51 070 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | −124 700 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | −8 513 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | −21 075 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 38,2500 | −6 973 | −267 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −68 100 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −121 300 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | −75 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 16,30 | −165 050 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | −180 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | −105 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −85 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | −11 325 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | −25 950 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Common Stock | D | 38,2500 | −2 367 | −91 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −61 500 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −76 144 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | −270 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | −17 325 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | −10 275 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 38,2500 | −14 813 | −567 | 0 | ||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | −15 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | −21 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | −33 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | −25 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,13 | −8 000 | 0 | |||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Common Stock | D | 38,2500 | −4 666 | −178 | 0 | ||||
2021-12-17 | 2021-12-15 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | −2 837 | 8 513 | ||||||
2021-12-17 | 2021-12-15 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 38,0500 | −833 | −32 | 6 973 | ||||
2021-12-17 | 2021-12-15 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 2 837 | 7 806 | ||||||
2021-12-17 | 2021-12-15 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | −3 425 | 10 275 | ||||||
2021-12-17 | 2021-12-15 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 38,0500 | −1 241 | −47 | 14 813 | ||||
2021-12-17 | 2021-12-15 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 3 425 | 16 054 | ||||||
2021-12-17 | 2021-12-15 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | −2 050 | 6 150 | ||||||
2021-12-17 | 2021-12-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 38,0500 | −602 | −23 | 7 775 | ||||
2021-12-17 | 2021-12-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 2 050 | 8 377 | ||||||
2021-12-17 | 2021-12-15 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | −2 562 | 7 688 | ||||||
2021-12-17 | 2021-12-15 | 4 | Zeng Ling | DRNA | Common Stock | D | 38,0500 | −752 | −29 | 5 032 | ||||
2021-12-17 | 2021-12-15 | 4 | Zeng Ling | DRNA | Common Stock | D | 2 562 | 5 784 | ||||||
2021-12-17 | 2021-12-15 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | −3 775 | 11 325 | ||||||
2021-12-17 | 2021-12-15 | 4 | Brown Bob D | DRNA | Common Stock | D | 38,0500 | −1 675 | −64 | 2 367 | ||||
2021-12-17 | 2021-12-15 | 4 | Brown Bob D | DRNA | Common Stock | D | 3 775 | 4 042 | ||||||
2021-12-17 | 2021-12-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | −13 750 | 41 250 | ||||||
2021-12-17 | 2021-12-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 38,0500 | −5 348 | −203 | 231 431 | ||||
2021-12-17 | 2021-12-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 13 750 | 236 779 | ||||||
2021-12-17 | 2021-12-15 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | −3 775 | 11 325 | ||||||
2021-12-17 | 2021-12-15 | 4 | Weissman James B | DRNA | Common Stock | D | 38,0500 | −1 675 | −64 | 18 100 | ||||
2021-12-17 | 2021-12-15 | 4 | Weissman James B | DRNA | Common Stock | D | 3 775 | 19 775 | ||||||
2021-12-14 | 2021-12-13 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −8 856 | 76 144 | |||||
2021-12-14 | 2021-12-13 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 22,5800 | 8 856 | 200 | 12 629 | ||||
2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −146 195 | 55 055 | |||||
2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −33 670 | 191 330 | |||||
2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 146 195 | 500 | 223 029 | ||||
2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 2,9700 | 33 670 | 100 | 76 834 | ||||
2021-11-22 | 2021-11-18 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −24 936 | 0 | |||||
2021-11-22 | 2021-11-18 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,9400 | −24 936 | −946 | 267 | ||||
2021-11-22 | 2021-11-18 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 24 936 | 85 | 25 203 | ||||
2021-09-21 | 2021-09-17 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0596 | −21 250 | −448 | 267 | ||||
2021-09-17 | 2021-09-17 | 4 | Zeng Ling | DRNA | Common Stock | D | 21,4700 | −1 334 | −29 | 3 222 | ||||
2021-09-17 | 2021-09-15 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | −4 556 | 13 669 | ||||||
2021-09-17 | 2021-09-15 | 4 | Zeng Ling | DRNA | Common Stock | D | 4 556 | 4 556 | ||||||
2021-09-17 | 2021-09-17 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 21,4700 | −2 056 | −44 | 4 969 | ||||
2021-09-17 | 2021-09-15 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | −7 025 | 21 075 | ||||||
2021-09-17 | 2021-09-15 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 7 025 | 7 025 | ||||||
2021-08-10 | 2021-08-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 22,0960 | 5 000 | 110 | 43 164 | ||||
2021-08-10 | 2021-08-10 | 4 | KOZIN MARC D | DRNA | Common Stock | D | 23,6620 | 3 000 | 71 | 6 333 | ||||
2021-08-03 | 2021-08-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 312 | 24 936 | |||||
2021-08-03 | 2021-08-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,3770 | −8 312 | −311 | 21 517 | ||||
2021-08-03 | 2021-08-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 312 | 28 | 29 829 | ||||
2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | −1 712 | 11 988 | ||||||
2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | −1 450 | 7 250 | ||||||
2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 37,0500 | −1 404 | −52 | 2 027 | ||||
2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 1 712 | 3 431 | ||||||
2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 1 450 | 1 719 | ||||||
2021-07-08 | 2021-07-06 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −30 000 | 33 999 | |||||
2021-07-08 | 2021-07-06 | 4 | Weissman James B | DRNA | Common Stock | D | 39,0900 | −30 000 | −1 173 | 16 000 | ||||
2021-07-08 | 2021-07-06 | 4 | Weissman James B | DRNA | Common Stock | D | 9,0900 | 30 000 | 273 | 46 000 | ||||
2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 312 | 33 248 | |||||
2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,8466 | −1 066 | −40 | 21 517 | ||||
2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,3029 | −7 246 | −270 | 22 583 | ||||
2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 312 | 28 | 29 829 | ||||
2021-06-29 | 2021-06-25 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −1 000 | 49 221 | |||||
2021-06-29 | 2021-06-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 38,0037 | −1 000 | −38 | 269 | ||||
2021-06-29 | 2021-06-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,5800 | 1 000 | 23 | 1 269 | ||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −2 406 | 55 094 | |||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −2 279 | 50 221 | |||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −13 750 | 85 000 | |||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 36,7108 | −4 880 | −179 | 269 | ||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 37,0957 | −13 555 | −503 | 5 149 | ||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 24,0500 | 2 406 | 58 | 18 704 | ||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,5800 | 2 279 | 51 | 16 298 | ||||
2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 13 750 | 178 | 14 019 | ||||
2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | −4 000 | 57 500 | |||||
2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 664 | 98 750 | |||||
2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 35,7881 | −8 664 | −310 | 269 | ||||
2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 24,0500 | 4 000 | 96 | 8 933 | ||||
2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 664 | 60 | 4 933 | ||||
2021-06-17 | 2021-06-15 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | −6 825 | 20 475 | ||||||
2021-06-17 | 2021-06-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 35,7400 | −2 004 | −72 | 5 760 | ||||
2021-06-17 | 2021-06-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 6 825 | 7 764 | ||||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 26,62 | −1 564 | 5 261 | |||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | −10 000 | 52 500 | |||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −20 000 | 103 414 | |||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 36,1500 | −100 | −4 | 269 | ||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 35,6284 | −31 464 | −1 121 | 369 | ||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 26,6200 | 1 564 | 42 | 31 833 | ||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,5800 | 10 000 | 226 | 30 269 | ||||
2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 20 000 | 259 | 20 269 | ||||
2021-06-17 | 2021-06-15 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | −381 | 1 144 | ||||||
2021-06-17 | 2021-06-15 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 35,7400 | −112 | −4 | 269 | ||||
2021-06-17 | 2021-06-15 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 381 | 381 | ||||||
2021-06-15 | 2021-06-14 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | −20 000 | 270 000 | |||||
2021-06-15 | 2021-06-14 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 38,0000 | −20 000 | −760 | 3 773 | ||||
2021-06-15 | 2021-06-14 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 15,6100 | 20 000 | 312 | 23 773 | ||||
2021-06-15 | 2021-06-11 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | −10 000 | 290 000 | |||||
2021-06-15 | 2021-06-11 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 35,0000 | −10 000 | −350 | 3 773 | ||||
2021-06-15 | 2021-06-11 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 15,6100 | 10 000 | 156 | 13 773 | ||||
2021-06-15 | 2021-06-11 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −10 000 | 85 000 | |||||
2021-06-15 | 2021-06-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 34,0000 | −10 000 | −340 | 21 517 | ||||
2021-06-15 | 2021-06-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10 000 | 91 | 31 517 | ||||
2021-06-08 | 2021-06-07 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −10 000 | 95 000 | |||||
2021-06-08 | 2021-06-07 | 4 | Brown Bob D | DRNA | Common Stock | D | 33,0000 | −10 000 | −330 | 21 517 | ||||
2021-06-08 | 2021-06-07 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10 000 | 91 | 31 517 | ||||
2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | D | 3 333 | 29 071 | ||||||
2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Protopapas Anna | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | Protopapas Anna | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | −4 666 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Common Stock | D | 4 666 | 4 666 | ||||||
2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15 000 | 15 000 | |||||
2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | −3 333 | 0 | ||||||
2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Common Stock | D | 3 333 | 3 333 | ||||||
2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 431 | 123 414 | |||||
2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 31,9687 | −305 | −10 | 0 | ||||
2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 30,8599 | −4 126 | −127 | 305 | ||||
2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 431 | 57 | 4 431 | ||||
2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 312 | 41 560 | |||||
2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 32,0165 | −342 | −11 | 21 517 | ||||
2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 30,8818 | −7 970 | −246 | 21 859 | ||||
2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 312 | 28 | 29 829 | ||||
2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 431 | 127 845 | |||||
2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 31,2485 | −475 | −15 | 0 | ||||
2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 30,1692 | −3 956 | −119 | 475 | ||||
2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 431 | 57 | 4 431 | ||||
2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 312 | 49 872 | |||||
2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 31,6600 | −24 | −1 | 21 517 | ||||
2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 31,0103 | −1 135 | −35 | 21 541 | ||||
2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 30,1574 | −7 153 | −216 | 22 676 | ||||
2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 312 | 28 | 29 829 | ||||
2021-05-03 | 2021-04-30 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −10 000 | 105 000 | |||||
2021-05-03 | 2021-04-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 32,0000 | −10 000 | −320 | 21 517 | ||||
2021-05-03 | 2021-04-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10 000 | 91 | 31 517 | ||||
2021-05-03 | 2021-04-29 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −10 000 | 115 000 | |||||
2021-05-03 | 2021-04-29 | 4 | Brown Bob D | DRNA | Common Stock | D | 31,0000 | −10 000 | −310 | 21 517 | ||||
2021-05-03 | 2021-04-29 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10 000 | 91 | 31 517 | ||||
2021-04-20 | 2021-04-16 | 4 | Weissman James B | DRNA | Common Stock | D | 29,9900 | −4 904 | −147 | 16 000 | ||||
2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 312 | 58 184 | |||||
2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 26,4950 | −188 | −5 | 21 517 | ||||
2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,8548 | −8 124 | −210 | 21 705 | ||||
2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 312 | 28 | 29 829 | ||||
2021-04-05 | 2021-03-01 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 312 | 66 496 | |||||
2021-04-05 | 2021-03-01 | 4/A | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 312 | 28 | 29 829 | ||||
2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −5 246 | 0 | |||||
2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −3 066 | 74 808 | |||||
2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 5 246 | 16 | 29 829 | ||||
2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 3 066 | 10 | 24 583 | ||||
2021-04-05 | 2021-01-25 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −16 630 | 5 246 | |||||
2021-04-05 | 2021-01-25 | 4/A | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 16 630 | 49 | 43 147 | ||||
2021-04-05 | 2021-04-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 431 | 132 276 | |||||
2021-04-05 | 2021-04-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 25,8551 | −4 431 | −115 | 0 | ||||
2021-04-05 | 2021-04-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 431 | 57 | 4 431 | ||||
2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −8 312 | 91 746 | |||||
2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 29,4889 | −783 | −23 | 21 517 | ||||
2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 28,9031 | −7 529 | −218 | 22 300 | ||||
2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 8 312 | 76 | 29 829 | ||||
2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 431 | 136 707 | |||||
2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 29,4699 | −356 | −10 | 0 | ||||
2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 28,9197 | −4 075 | −118 | 356 | ||||
2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 431 | 57 | 4 431 | ||||
2021-02-08 | 2021-02-05 | 4 | Weissman James B | DRNA | Common Stock | D | 26,9900 | −7 156 | −193 | 20 904 | ||||
2021-02-04 | 2021-02-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −8 312 | 100 058 | |||||
2021-02-04 | 2021-02-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,0000 | −8 312 | −208 | 21 517 | ||||
2021-02-04 | 2021-02-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 8 312 | 76 | 29 829 | ||||
2021-02-04 | 2021-02-02 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 431 | 141 138 | |||||
2021-02-04 | 2021-02-02 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 24,0000 | −4 431 | −106 | 0 | ||||
2021-02-04 | 2021-02-02 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 431 | 57 | 4 431 | ||||
2021-01-27 | 2021-01-25 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −16 630 | 108 370 | |||||
2021-01-27 | 2021-01-25 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,0000 | −21 630 | −541 | 21 517 | ||||
2021-01-27 | 2021-01-25 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 16 630 | 151 | 43 147 | ||||
2021-01-27 | 2021-01-25 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −4 431 | 145 569 | |||||
2021-01-27 | 2021-01-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 25,0000 | −6 326 | −158 | 0 | ||||
2021-01-27 | 2021-01-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4 431 | 57 | 6 326 | ||||
2021-01-13 | 2021-01-12 | 4 | Weissman James B | DRNA | Common Stock | D | 24,0820 | −5 808 | −140 | 28 060 | ||||
2021-01-13 | 2021-01-12 | 4 | Brown Bob D | DRNA | Common Stock | D | 24,0732 | −5 808 | −140 | 26 517 | ||||
2021-01-12 | 2021-01-12 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 51 070 | 51 070 | |||||
2021-01-12 | 2021-01-12 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | 11 350 | 11 350 | ||||||
2021-01-12 | 2021-01-12 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 68 100 | 68 100 | |||||
2021-01-12 | 2021-01-12 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | 15 100 | 15 100 | ||||||
2021-01-12 | 2021-01-11 | 4 | Weissman James B | DRNA | Common Stock | D | 23,9900 | −3 800 | −91 | 33 868 | ||||
2021-01-12 | 2021-01-08 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | −8 650 | 25 950 | ||||||
2021-01-12 | 2021-01-08 | 4 | Weissman James B | DRNA | Common Stock | D | 23,2900 | −2 842 | −66 | 37 668 | ||||
2021-01-12 | 2021-01-08 | 4 | Weissman James B | DRNA | Common Stock | D | 8 650 | 40 510 | ||||||
2021-01-12 | 2021-01-12 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 247 700 | 247 700 | |||||
2021-01-12 | 2021-01-12 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | 55 000 | 55 000 | ||||||
2021-01-12 | 2021-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | −19 950 | 59 850 | ||||||
2021-01-12 | 2021-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 23,2900 | −6 159 | −143 | 37 030 | ||||
2021-01-12 | 2021-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 19 950 | 43 189 | ||||||
2021-01-12 | 2021-01-12 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 68 100 | 68 100 | |||||
2021-01-12 | 2021-01-12 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | 15 100 | 15 100 | ||||||
2021-01-12 | 2021-01-08 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | −8 650 | 25 950 | ||||||
2021-01-12 | 2021-01-08 | 4 | Brown Bob D | DRNA | Common Stock | D | 23,2900 | −2 842 | −66 | 32 325 | ||||
2021-01-12 | 2021-01-08 | 4 | Brown Bob D | DRNA | Common Stock | D | 8 650 | 35 167 | ||||||
2021-01-12 | 2021-01-12 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 46 120 | 46 120 | |||||
2021-01-12 | 2021-01-12 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | 10 250 | 10 250 | ||||||
2021-01-12 | 2021-01-12 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 36 900 | 36 900 | |||||
2021-01-12 | 2021-01-12 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | 8 200 | 8 200 | ||||||
2021-01-12 | 2021-01-12 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 61 500 | 61 500 | |||||
2021-01-12 | 2021-01-12 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | 13 700 | 13 700 | ||||||
2021-01-12 | 2021-01-08 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | −2 900 | 8 700 | ||||||
2021-01-12 | 2021-01-08 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 23,2900 | −1 005 | −23 | 1 895 | ||||
2021-01-12 | 2021-01-08 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 2 900 | 2 900 | ||||||
2021-01-12 | 2021-01-12 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 61 500 | 61 500 | |||||
2021-01-12 | 2021-01-12 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | 13 700 | 13 700 | ||||||
2021-01-12 | 2021-01-08 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | −5 775 | 17 325 | ||||||
2021-01-12 | 2021-01-08 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 23,2900 | −2 002 | −47 | 3 773 | ||||
2021-01-12 | 2021-01-08 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 5 775 | 5 775 | ||||||
2020-12-14 | 2020-12-10 | 4 | Koppel Adam See footnotes | DRNA | Common Stock | I | 23,4000 | −1 000 000 | −23 400 | 3 080 237 | ||||
2020-12-03 | 2020-12-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 0 | |||||
2020-12-03 | 2020-12-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,1931 | −8 185 | −206 | 26 517 | ||||
2020-12-03 | 2020-12-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 34 702 | ||||
2020-12-03 | 2020-12-01 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −4 360 | 0 | |||||
2020-12-03 | 2020-12-01 | 4 | Weissman James B | DRNA | Common Stock | D | 25,2071 | −4 360 | −110 | 31 860 | ||||
2020-12-03 | 2020-12-01 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 4 360 | 15 | 36 220 | ||||
2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | −30 000 | 150 000 | |||||
2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 23,2500 | −15 000 | −349 | 0 | ||||
2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,2500 | −15 000 | −334 | 15 000 | ||||
2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 30 000 | 388 | 30 000 | ||||
2020-11-03 | 2020-11-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 8 185 | |||||
2020-11-03 | 2020-11-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0300 | −8 185 | −172 | 26 517 | ||||
2020-11-03 | 2020-11-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 34 702 | ||||
2020-11-03 | 2020-11-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −4 360 | 4 360 | |||||
2020-11-03 | 2020-11-02 | 4 | Weissman James B | DRNA | Common Stock | D | 20,9480 | −4 360 | −91 | 31 860 | ||||
2020-11-03 | 2020-11-02 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 4 360 | 15 | 36 220 | ||||
2020-10-22 | 2020-10-20 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −10 000 | 11 879 | |||||
2020-10-22 | 2020-10-20 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 10 000 | 30 | 31 860 | ||||
2020-10-20 | 2020-10-16 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −16 370 | 16 370 | |||||
2020-10-20 | 2020-10-16 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | −16 370 | −344 | 26 517 | ||||
2020-10-20 | 2020-10-16 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 16 370 | 56 | 42 887 | ||||
2020-10-19 | 2020-10-15 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 720 | 8 720 | |||||
2020-10-19 | 2020-10-15 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | −8 720 | −176 | 21 860 | ||||
2020-10-19 | 2020-10-15 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 8 720 | 30 | 30 580 | ||||
2020-10-02 | 2020-10-01 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | 124 700 | 124 700 | |||||
2020-10-02 | 2020-10-01 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | 28 100 | 28 100 | ||||||
2020-10-02 | 2020-10-01 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | 81 825 | 81 825 | |||||
2020-10-02 | 2020-10-01 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | 18 225 | 18 225 | ||||||
2020-09-18 | 2020-09-16 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −21 250 | 77 874 | |||||
2020-09-18 | 2020-09-16 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 21 250 | 73 | 26 517 | ||||
2020-09-16 | 2020-09-14 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −267 | 0 | |||||
2020-09-16 | 2020-09-14 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 267 | 1 | 5 267 | ||||
2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 360 | 25 980 | |||||
2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Common Stock | D | 26,8678 | −1 307 | −35 | 21 860 | ||||
2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Common Stock | D | 26,3881 | −3 053 | −81 | 23 167 | ||||
2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-09-01 | 2020-09-01 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 18,0597 | 10 000 | 181 | 22 300 | ||||
2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 32 740 | |||||
2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,7999 | −2 521 | −57 | 5 000 | ||||
2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,3355 | −5 664 | −127 | 7 521 | ||||
2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 13 185 | ||||
2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −259 | 17 440 | |||||
2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 101 | 21 879 | |||||
2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 22,7993 | −1 432 | −33 | 21 860 | ||||
2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 22,3120 | −2 928 | −65 | 23 292 | ||||
2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 259 | 1 | 26 220 | ||||
2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 101 | 12 | 25 961 | ||||
2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 360 | 25 980 | |||||
2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Common Stock | D | 26,8678 | −1 307 | −35 | 21 860 | ||||
2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Common Stock | D | 26,3881 | −3 053 | −81 | 23 167 | ||||
2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 40 925 | |||||
2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 26,8533 | −2 371 | −64 | 5 000 | ||||
2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 26,3604 | −5 814 | −153 | 7 371 | ||||
2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 13 185 | ||||
2020-07-02 | 2020-07-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 26,62 | 6 825 | 6 825 | |||||
2020-07-02 | 2020-07-01 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | 1 525 | 1 525 | ||||||
2020-06-23 | 2020-06-19 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −9 670 | 21 876 | |||||
2020-06-23 | 2020-06-19 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,0000 | −9 670 | −242 | 5 000 | ||||
2020-06-23 | 2020-06-19 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 9 670 | 29 | 14 670 | ||||
2020-06-16 | 2020-06-15 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 21 000 | 21 000 | |||||
2020-06-16 | 2020-06-15 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | 4 666 | 4 666 | ||||||
2020-06-16 | 2020-06-15 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | Protopapas Anna | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | Protopapas Anna | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-16 | 2020-06-15 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15 000 | 15 000 | |||||
2020-06-16 | 2020-06-15 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | 3 333 | 3 333 | ||||||
2020-06-02 | 2020-06-01 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 20,79 | 95 650 | 95 650 | |||||
2020-06-02 | 2020-06-01 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | 27 300 | 27 300 | ||||||
2020-06-02 | 2020-06-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 49 110 | |||||
2020-06-02 | 2020-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0091 | −8 185 | −172 | 5 000 | ||||
2020-06-02 | 2020-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 13 185 | ||||
2020-06-02 | 2020-06-01 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 360 | 30 340 | |||||
2020-06-02 | 2020-06-01 | 4 | Weissman James B | DRNA | Common Stock | D | 21,0567 | −4 360 | −92 | 21 860 | ||||
2020-06-02 | 2020-06-01 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-05-12 | 2020-05-11 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −13 281 | 31 546 | |||||
2020-05-12 | 2020-05-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 24,0000 | −13 281 | −319 | 5 000 | ||||
2020-05-12 | 2020-05-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 13 281 | 39 | 18 281 | ||||
2020-05-07 | 2020-05-05 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 57 295 | |||||
2020-05-07 | 2020-05-05 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | −8 185 | −172 | 5 000 | ||||
2020-05-07 | 2020-05-05 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 13 185 | ||||
2020-05-06 | 2020-05-04 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 4 360 | 34 700 | |||||
2020-05-06 | 2020-05-04 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | −4 360 | −88 | 21 860 | ||||
2020-05-06 | 2020-05-04 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-04-22 | 2020-04-20 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | −25 624 | 186 375 | |||||
2020-04-22 | 2020-04-20 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 22,9500 | −25 624 | −588 | 19 421 | ||||
2020-04-22 | 2020-04-20 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 25 624 | 140 | 45 045 | ||||
2020-04-21 | 2020-04-20 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −13 281 | 44 827 | |||||
2020-04-21 | 2020-04-20 | 4 | Brown Bob D | DRNA | Common Stock | D | 23,0000 | −13 281 | −305 | 5 000 | ||||
2020-04-21 | 2020-04-20 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 13 281 | 39 | 18 281 | ||||
2020-04-21 | 2020-04-17 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 65 480 | |||||
2020-04-21 | 2020-04-17 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,1800 | −8 185 | −173 | 5 000 | ||||
2020-04-21 | 2020-04-17 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 13 185 | ||||
2020-04-14 | 2020-04-13 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 360 | 39 060 | |||||
2020-04-14 | 2020-04-13 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | −4 360 | −88 | 21 860 | ||||
2020-04-14 | 2020-04-13 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −12 968 | 14 063 | |||||
2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | −7 501 | 211 999 | |||||
2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 19,9500 | −20 469 | −408 | 19 421 | ||||
2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 2,9700 | 12 968 | 39 | 39 890 | ||||
2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 7 501 | 41 | 26 922 | ||||
2020-03-16 | 2020-03-12 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 15,61 | 25 000 | 25 000 | |||||
2020-03-03 | 2020-03-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 360 | 43 420 | |||||
2020-03-03 | 2020-03-02 | 4 | Weissman James B | DRNA | Common Stock | D | 20,6087 | −4 360 | −90 | 21 860 | ||||
2020-03-03 | 2020-03-02 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-03-03 | 2020-03-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 73 665 | |||||
2020-03-03 | 2020-03-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | −8 185 | −172 | 5 000 | ||||
2020-03-03 | 2020-03-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 13 185 | ||||
2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −2 535 | 99 124 | |||||
2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −5 650 | 81 850 | |||||
2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | −8 185 | −172 | 5 000 | ||||
2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 2 535 | 9 | 13 185 | ||||
2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 5 650 | 19 | 10 650 | ||||
2020-02-04 | 2020-02-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 360 | 47 780 | |||||
2020-02-04 | 2020-02-03 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | −4 360 | −88 | 21 860 | ||||
2020-02-04 | 2020-02-03 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4 360 | 13 | 26 220 | ||||
2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −20 469 | 27 031 | |||||
2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −27 500 | 47 500 | |||||
2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 21,2628 | −20 469 | −435 | 19 421 | ||||
2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 21,2704 | −27 500 | −585 | 39 890 | ||||
2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 2,9700 | 20 469 | 61 | 67 390 | ||||
2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 2,9700 | 27 500 | 82 | 46 921 | ||||
2020-01-10 | 2020-01-08 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 85 000 | 85 000 | |||||
2020-01-10 | 2020-01-08 | 4 | GREEN JOHN B | DRNA | Restricted Stock Units | D | 23 100 | 23 100 | ||||||
2020-01-10 | 2020-01-08 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 85 000 | 85 000 | |||||
2020-01-10 | 2020-01-08 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | 23 100 | 23 100 | ||||||
2020-01-10 | 2020-01-08 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 121 300 | 121 300 | |||||
2020-01-10 | 2020-01-08 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | 34 600 | 34 600 | ||||||
2020-01-10 | 2020-01-08 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 85 000 | 85 000 | |||||
2020-01-10 | 2020-01-08 | 4 | ROSSKAMP RALF | DRNA | Restricted Stock Units | D | 23 100 | 23 100 | ||||||
2020-01-10 | 2020-01-08 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 121 300 | 121 300 | |||||
2020-01-10 | 2020-01-08 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | 34 600 | 34 600 | ||||||
2020-01-10 | 2020-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 250 000 | 250 000 | |||||
2020-01-10 | 2020-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | 79 800 | 79 800 | ||||||
2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −2 860 | 52 140 | |||||
2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −1 500 | 0 | |||||
2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Common Stock | D | 21,8753 | −4 360 | −95 | 21 860 | ||||
2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 2 860 | 8 | 26 220 | ||||
2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 1 500 | 5 | 23 360 | ||||
2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −11 941 | 58 108 | |||||
2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −5 000 | 101 659 | |||||
2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,0000 | −11 941 | −263 | 5 000 | ||||
2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 11 941 | 35 | 16 941 | ||||
2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 5 000 | 17 | 5 000 | ||||
2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −4 951 | 70 049 | |||||
2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −8 185 | 106 659 | |||||
2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,0051 | −1 340 | −29 | 0 | ||||
2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,8445 | −21 466 | −469 | 1 340 | ||||
2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 4 951 | 15 | 22 806 | ||||
2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8 185 | 28 | 17 855 | ||||
2019-12-27 | 2019-12-26 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 2,91 | −20 000 | 230 000 | |||||
2019-12-27 | 2019-12-26 | 4 | ROSSKAMP RALF | DRNA | Common Stock | D | 22,6882 | −20 000 | −454 | 3 564 | ||||
2019-12-27 | 2019-12-26 | 4 | ROSSKAMP RALF | DRNA | Common Stock | D | 2,9100 | 20 000 | 58 | 23 564 | ||||
2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −80 000 | 201 250 | |||||
2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 27,0735 | −1 431 | −39 | 12 300 | ||||
2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 25,8479 | −78 569 | −2 031 | 13 731 | ||||
2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 80 000 | 274 | 92 300 | ||||
2019-12-19 | 2019-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 26,9443 | −2 305 | −62 | 12 300 | ||||
2019-12-19 | 2019-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 26,1344 | −56 716 | −1 482 | 14 605 | ||||
2019-12-19 | 2019-12-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −11 001 | 63 999 | |||||
2019-12-19 | 2019-12-18 | 4 | Weissman James B | DRNA | Common Stock | D | 26,0100 | −3 845 | −100 | 21 860 | ||||
2019-12-19 | 2019-12-18 | 4 | Weissman James B | DRNA | Common Stock | D | 9,0900 | 11 001 | 100 | 25 705 | ||||
2019-12-11 | 2019-12-11 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | −8 000 | 219 500 | |||||
2019-12-11 | 2019-12-11 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 8 000 | 44 | 18 698 | ||||
2019-12-06 | 2019-12-04 | 4 | Koppel Adam See footnotes | DRNA | Common Stock | I | 24,6800 | −1 500 000 | −37 020 | 4 080 237 | ||||
2019-12-03 | 2019-12-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | −20 000 | 55 000 | |||||
2019-12-03 | 2019-12-02 | 4 | Weissman James B | DRNA | Common Stock | D | 26,0000 | −20 000 | −520 | 14 704 | ||||
2019-12-03 | 2019-12-02 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 20 000 | 59 | 34 704 | ||||
2019-12-02 | 2019-12-02 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,9835 | −137 176 | −3 427 | 0 | ||||
2019-12-02 | 2019-11-29 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,2154 | −138 000 | −3 342 | 137 176 | ||||
2019-12-02 | 2019-11-27 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,0433 | −368 700 | −8 865 | 275 176 | ||||
2019-11-27 | 2019-11-25 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | −12 500 | 227 500 | |||||
2019-11-27 | 2019-11-25 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 24,9500 | −12 500 | −312 | 10 698 | ||||
2019-11-27 | 2019-11-25 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 12 500 | 68 | 23 198 | ||||
2019-11-26 | 2019-11-26 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 23,5855 | −239 700 | −5 653 | 643 876 | ||||
2019-11-26 | 2019-11-25 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,0578 | −361 200 | −8 690 | 883 576 | ||||
2019-11-26 | 2019-11-22 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 22,5164 | −197 700 | −4 451 | 1 244 776 | ||||
2019-11-21 | 2019-11-19 | 4 | Bain Capital Life Sciences Investors, LLC See Footnotes | DRNA | Common Stock | I | 22,0300 | −1 750 000 | −38 552 | 5 580 237 | ||||
2019-11-21 | 2019-11-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 22,9782 | −351 505 | −8 077 | 1 442 476 | ||||
2019-11-21 | 2019-11-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 22,9332 | −265 505 | −6 089 | 1 793 981 | ||||
2019-11-21 | 2019-11-19 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 23,9217 | −397 183 | −9 501 | 2 059 486 | ||||
2019-11-20 | 2019-11-18 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | −12 500 | 240 000 | |||||
2019-11-20 | 2019-11-18 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 21,0500 | −12 500 | −263 | 10 698 | ||||
2019-11-20 | 2019-11-18 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 12 500 | 68 | 23 198 | ||||
2019-11-20 | 2019-11-19 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −20 000 | 0 | |||||
2019-11-20 | 2019-11-19 | 4 | Weissman James B | DRNA | Common Stock | D | 24,0000 | −20 000 | −480 | 14 704 | ||||
2019-11-20 | 2019-11-19 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 20 000 | 68 | 34 704 | ||||
2019-11-20 | 2019-11-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −20 000 | 20 000 | |||||
2019-11-20 | 2019-11-18 | 4 | Weissman James B | DRNA | Common Stock | D | 22,0000 | −20 000 | −440 | 14 704 | ||||
2019-11-20 | 2019-11-18 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 20 000 | 68 | 34 704 | ||||
2019-11-15 | 2019-11-14 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 20,0000 | −3 562 | −71 | 10 698 | ||||
2019-11-15 | 2019-11-14 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −20 000 | 40 000 | |||||
2019-11-15 | 2019-11-14 | 4 | Weissman James B | DRNA | Common Stock | D | 20,0000 | −20 000 | −400 | 14 704 | ||||
2019-11-15 | 2019-11-14 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 20 000 | 68 | 34 704 | ||||
2019-11-01 | 2019-10-31 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −15 000 | 17 699 | |||||
2019-11-01 | 2019-10-31 | 4 | Weissman James B | DRNA | Common Stock | D | 18,0000 | −15 000 | −270 | 14 704 | ||||
2019-11-01 | 2019-10-31 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 15 000 | 51 | 29 704 | ||||
2019-11-01 | 2019-10-31 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | −12 500 | 252 500 | |||||
2019-11-01 | 2019-10-31 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 18,0000 | −12 500 | −225 | 14 260 | ||||
2019-11-01 | 2019-10-31 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 12 500 | 68 | 26 760 | ||||
2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −4 104 | 60 000 | |||||
2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −800 | 0 | |||||
2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 4 104 | 14 | 14 704 | ||||
2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 800 | 3 | 10 600 | ||||
2019-09-19 | 2019-09-17 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 14,32 | 25 000 | 25 000 | |||||
2019-08-23 | 2019-08-23 | 4 | Weissman James B | DRNA | Common Stock | D | 13,0676 | −14 680 | −192 | 9 800 | ||||
2019-07-01 | 2019-07-01 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | 300 000 | 300 000 | |||||
2019-06-21 | 2019-06-20 | 4 | Smith Cynthia | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | Freed Martin I | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (right to buy) | D | 15,44 | 33 000 | 33 000 | |||||
2019-06-21 | 2019-06-20 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | Protopapas Anna | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | Koppel Adam | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-06-21 | 2019-06-20 | 4 | KOZIN MARC D | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25 000 | 25 000 | |||||
2019-05-31 | 2019-05-29 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 12,5000 | −1 600 000 | −20 000 | 7 330 237 | ||||
2019-04-04 | 2019-04-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −15 000 | 32 699 | |||||
2019-04-04 | 2019-04-02 | 4 | Weissman James B | DRNA | Common Stock | D | 15,0000 | −15 000 | −225 | 24 480 | ||||
2019-04-04 | 2019-04-02 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 15 000 | 51 | 39 480 | ||||
2019-03-29 | 2019-03-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,13 | 8 000 | 8 000 | |||||
2019-01-25 | 2019-01-23 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 10,31 | 25 000 | 25 000 | |||||
2019-01-25 | 2019-01-23 | 4 | Protopapas Anna | DRNA | Director Stock Option (Right to Buy) | D | 10,31 | 25 000 | 25 000 | |||||
2019-01-25 | 3 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 10 000 | ||||||||
2019-01-25 | 3 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 10 000 | ||||||||
2019-01-25 | 3 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 10 000 | ||||||||
2019-01-04 | 2019-01-02 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180 000 | 180 000 | |||||
2019-01-04 | 2019-01-02 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 505 000 | 505 000 | |||||
2019-01-04 | 2019-01-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180 000 | 180 000 | |||||
2019-01-04 | 2019-01-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180 000 | 180 000 | |||||
2019-01-04 | 2019-01-02 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180 000 | 180 000 | |||||
2018-11-09 | 2018-11-08 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 14,8599 | −107 920 | −1 604 | 2 456 669 | ||||
2018-11-09 | 2018-11-07 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 14,7402 | −250 000 | −3 685 | 2 564 589 | ||||
2018-11-06 | 2018-11-06 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,8434 | −263 300 | −3 645 | 2 814 589 | ||||
2018-11-06 | 2018-11-05 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 12,8880 | −71 400 | −920 | 3 077 889 | ||||
2018-11-06 | 2018-11-02 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,4926 | −175 700 | −2 371 | 3 149 289 | ||||
2018-11-06 | 2018-11-06 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,1600 | −11 | −0 | 19 150 | ||||
2018-11-06 | 2018-11-06 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,1600 | −1 489 | −21 | 2 586 535 | ||||
2018-11-06 | 2018-11-06 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,1800 | −761 | −10 | 19 161 | ||||
2018-11-06 | 2018-11-06 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,1800 | −102 067 | −1 345 | 2 588 024 | ||||
2018-11-06 | 2018-11-05 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 12,9800 | −295 | −4 | 19 922 | ||||
2018-11-06 | 2018-11-05 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 12,9800 | −39 606 | −514 | 2 690 091 | ||||
2018-11-06 | 2018-11-02 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,4700 | −1 412 | −19 | 20 217 | ||||
2018-11-06 | 2018-11-02 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,4700 | −189 359 | −2 551 | 2 729 697 | ||||
2018-11-05 | 2018-11-01 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,3700 | −1 408 | −19 | 21 629 | ||||
2018-11-05 | 2018-11-01 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,3700 | −188 867 | −2 525 | 2 919 056 | ||||
2018-11-05 | 2018-10-31 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6000 | −959 | −13 | 23 037 | ||||
2018-11-05 | 2018-10-31 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6000 | −128 670 | −1 750 | 3 107 923 | ||||
2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,3100 | −678 | −10 | 23 996 | ||||
2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,3100 | −90 918 | −1 301 | 3 236 593 | ||||
2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6800 | −1 136 | −16 | 24 674 | ||||
2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6800 | −152 364 | −2 084 | 3 327 511 | ||||
2018-11-01 | 2018-11-01 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,3757 | −180 100 | −2 409 | 3 324 989 | ||||
2018-11-01 | 2018-10-31 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,4619 | −178 400 | −2 402 | 3 505 089 | ||||
2018-11-01 | 2018-10-30 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,8603 | −250 000 | −3 465 | 3 683 489 | ||||
2018-11-01 | 2018-11-01 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,3700 | −1 408 | −19 | 21 629 | ||||
2018-11-01 | 2018-11-01 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,3700 | −188 167 | −2 516 | 2 919 056 | ||||
2018-11-01 | 2018-10-31 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6000 | −959 | −13 | 23 037 | ||||
2018-11-01 | 2018-10-31 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6000 | −128 670 | −1 750 | 3 107 923 | ||||
2018-11-01 | 2018-10-30 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,3100 | −678 | −10 | 23 996 | ||||
2018-11-01 | 2018-10-30 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,3100 | −90 918 | −1 301 | 3 236 593 | ||||
2018-11-01 | 2018-10-30 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6800 | −1 136 | −16 | 24 674 | ||||
2018-11-01 | 2018-10-30 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6800 | −152 364 | −2 084 | 3 327 511 | ||||
2018-09-06 | 2018-09-05 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −2 301 | 47 699 | |||||
2018-09-06 | 2018-09-05 | 4 | Weissman James B | DRNA | Common Stock | D | 17,5000 | −2 301 | −40 | 24 480 | ||||
2018-09-06 | 2018-09-05 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 2 301 | 8 | 26 781 | ||||
2018-08-20 | 2018-08-17 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −14 680 | 64 104 | |||||
2018-08-20 | 2018-08-17 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 14 680 | 50 | 24 480 | ||||
2018-08-17 | 2018-08-15 | 4 | LANGER DENNIS | DRNA | Common Stock | D | 16,0000 | −14 531 | −232 | 29 064 | ||||
2018-08-17 | 2018-08-15 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 16,0000 | −23 810 | −381 | 47 978 | ||||
2018-08-15 | 2018-08-13 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | 25 000 | 25 000 | |||||
2018-08-15 | 2018-08-13 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | 25 000 | 25 000 | |||||
2018-06-26 | 2018-06-21 | 4 | Wise Bart W | DRNA | Employee Stock Option (Right to Buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-26 | 3 | Wise Bart W | DRNA | Common Stock | D | 11 294 | ||||||||
2018-06-26 | 3 | Wise Bart W | DRNA | Common Stock | D | 11 294 | ||||||||
2018-06-26 | 3 | Wise Bart W | DRNA | Common Stock | D | 11 294 | ||||||||
2018-06-25 | 2018-06-21 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-25 | 2018-06-21 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-25 | 2018-06-21 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-25 | 2018-06-21 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-25 | 2018-06-21 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 13,08 | 33 000 | 33 000 | |||||
2018-06-25 | 2018-06-21 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-25 | 2018-06-21 | 4 | Koppel Adam | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25 000 | 25 000 | |||||
2018-06-11 | 2018-06-07 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Warrant to Purchase Common Stock | I | 7,00 | −156 | 0 | |||||
2018-06-11 | 2018-06-07 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Warrant to Purchase Common Stock | I | 7,00 | −21 041 | 0 | |||||
2018-06-11 | 2018-06-07 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,4500 | −76 | −1 | 25 810 | ||||
2018-06-11 | 2018-06-07 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,4500 | −10 195 | −147 | 3 479 875 | ||||
2018-06-11 | 2018-06-07 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 7,0000 | 156 | 1 | 25 886 | ||||
2018-06-11 | 2018-06-07 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 7,0000 | 21 041 | 147 | 3 490 070 | ||||
2018-05-11 | 2018-05-09 | 4 | Brown Bob D | DRNA | Common Stock | D | 15,0000 | −9 669 | −145 | 9 670 | ||||
2018-05-11 | 2018-05-09 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −10 000 | 50 000 | |||||
2018-05-11 | 2018-05-09 | 4 | Weissman James B | DRNA | Common Stock | D | 15,0000 | −10 000 | −150 | 9 800 | ||||
2018-05-11 | 2018-05-09 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 10 000 | 34 | 19 800 | ||||
2018-04-24 | 2018-04-20 | 4 | Weissman James B | DRNA | Common Stock | D | 13,0000 | −8 965 | −117 | 9 800 | ||||
2018-03-27 | 2018-03-23 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,0511 | −55 300 | −611 | 3 933 489 | ||||
2018-03-21 | 2018-03-19 | 4 | Weissman James B | DRNA | Common Stock | D | 13,0000 | −1 035 | −13 | 18 765 | ||||
2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1727 | −36 224 | −405 | 3 988 789 | ||||
2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1400 | −49 000 | −546 | 4 025 013 | ||||
2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,0718 | −31 145 | −345 | 4 074 013 | ||||
2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,2399 | −64 600 | −726 | 4 105 158 | ||||
2018-03-21 | 2018-03-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1648 | −67 985 | −759 | 4 169 758 | ||||
2018-03-21 | 2018-03-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1555 | −55 200 | −616 | 4 237 743 | ||||
2018-03-21 | 2018-03-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,0000 | −50 000 | −550 | 4 292 943 | ||||
2018-03-21 | 2018-03-19 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 12,4550 | −34 700 | −432 | 4 342 943 | ||||
2018-03-21 | 2018-03-19 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 12,6308 | −84 670 | −1 069 | 4 377 643 | ||||
2018-01-30 | 2018-01-26 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Stock Option (Right to Buy) | I | 3,42 | −360 | 0 | |||||
2018-01-30 | 2018-01-26 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 3,4200 | 360 | 1 | 71 788 | ||||
2018-01-19 | 2018-01-18 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,2271 | −59 700 | −551 | 4 462 313 | ||||
2018-01-19 | 2018-01-17 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,3254 | −220 900 | −2 060 | 4 522 013 | ||||
2018-01-08 | 2018-01-04 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 105 000 | 105 000 | |||||
2018-01-08 | 2018-01-04 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 255 000 | 255 000 | |||||
2018-01-08 | 2018-01-04 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 105 000 | 105 000 | |||||
2018-01-08 | 2018-01-04 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 105 000 | 105 000 | |||||
2018-01-08 | 2018-01-04 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 57 750 | 57 750 | |||||
2018-01-08 | 2018-01-05 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1461 | −18 100 | −166 | 4 742 913 | ||||
2018-01-08 | 2018-01-04 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1978 | −77 400 | −712 | 4 761 013 | ||||
2018-01-03 | 2018-01-03 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,2533 | −59 100 | −547 | 4 838 413 | ||||
2018-01-03 | 2018-01-02 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,4655 | −68 000 | −644 | 4 897 513 | ||||
2018-01-03 | 2017-12-29 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1288 | −23 100 | −211 | 4 965 513 | ||||
2018-01-03 | 2017-12-29 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1026 | −85 400 | −777 | 4 988 613 | ||||
2017-12-20 | 2017-12-18 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | DRNA | Redeemable Convertible Preferred Stock | I | 3,1900 | −76 500 | −244 | 0 | ||||
2017-12-20 | 2017-12-18 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | DRNA | Common Stock | I | 2 645 442 | 5 074 013 | ||||||
2017-12-20 | 2017-12-18 | 4 | Kolchinsky Peter See Note | DRNA | Redeemable Convertible Preferred Stock | I | 3,1900 | −76 500 | −244 | 0 | ||||
2017-12-20 | 2017-12-18 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 2 645 442 | 5 074 013 | ||||||
2017-12-20 | 2017-12-18 | 4 | Domain Partners VIII, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | −49 632 | 0 | |||||
2017-12-20 | 2017-12-18 | 4 | Domain Partners VIII, L.P. | DRNA | Common Stock | D | 37 890 | 3 469 029 | ||||||
2017-12-20 | 2017-12-18 | 4 | Domain Partners VIII, L.P. | DRNA | Common Stock | D | 3,1900 | 1 678 432 | 5 354 | 3 431 139 | ||||
2017-12-20 | 2017-12-18 | 4 | DP VIII Associates, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | −368 | 0 | |||||
2017-12-20 | 2017-12-18 | 4 | DP VIII Associates, L.P. | DRNA | Common Stock | D | 282 | 25 730 | ||||||
2017-12-20 | 2017-12-18 | 4 | DP VIII Associates, L.P. | DRNA | Common Stock | D | 3,1900 | 12 444 | 40 | 25 448 | ||||
2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Redeemable Convertible Preferred Stock | I | 3,1900 | −250 000 | −798 | 0 | ||||
2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 190 849 | 8 930 237 | ||||||
2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 8 454 388 | 8 739 388 | ||||||
2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 7,0000 | 285 000 | 1 995 | 285 000 | ||||
2017-07-24 | 2017-07-18 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-07-20 | 2017-07-18 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-07-20 | 2017-07-18 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-07-20 | 2017-07-18 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-07-20 | 2017-07-18 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-07-20 | 2017-07-18 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 3,42 | 33 000 | 33 000 | |||||
2017-07-20 | 2017-07-18 | 4 | Koppel Adam | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-07-20 | 2017-07-18 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 3,42 | 25 000 | 25 000 | |||||
2017-06-16 | 2017-06-15 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 2,91 | 250 000 | 250 000 | |||||
2017-04-13 | 2017-04-11 | 4 | Koppel Adam | DRNA | Employee Stock Option (Right to buy) | D | 3,47 | 25 000 | 25 000 | |||||
2017-04-13 | 2017-04-11 | 4 | RA CAPITAL MANAGEMENT, LLC See Note 1 | DRNA | Redeemable Convertible Preferred Stock | I | 3,19 | 100,0000 | 76 500 | 7 650 | 76 500 | |||
2017-04-12 | 2017-04-11 | 4 | DP VIII Associates, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | 100,0000 | 368 | 37 | 368 | |||
2017-04-12 | 2017-04-11 | 4 | Domain Partners VIII, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | 100,0000 | 49 632 | 4 963 | 49 632 | |||
2017-01-05 | 2017-01-03 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 75 000 | 75 000 | |||||
2017-01-05 | 2017-01-03 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 225 000 | 225 000 | |||||
2017-01-05 | 2017-01-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy | D | 2,97 | 75 000 | 75 000 | |||||
2017-01-05 | 2017-01-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 75 000 | 75 000 | |||||
2016-11-17 | 2016-11-16 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 3,5200 | −23 766 | −84 | 71 428 | ||||
2016-11-16 | 2016-11-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,6300 | 16 500 | 60 | 55 579 | ||||
2016-11-16 | 2016-11-14 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,7800 | 16 600 | 63 | 39 079 | ||||
2016-06-16 | 2016-06-14 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 3,26 | 15 000 | 15 000 | |||||
2016-06-15 | 2016-06-14 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15 000 | 15 000 | |||||
2016-06-15 | 2016-06-14 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15 000 | 15 000 | |||||
2016-06-15 | 2016-06-14 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15 000 | 15 000 | |||||
2016-06-15 | 2016-06-14 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 3,26 | 20 000 | 20 000 | |||||
2016-06-15 | 2016-06-14 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15 000 | 15 000 | |||||
2016-06-15 | 2016-06-14 | 4 | Freed Martin I | DRNA | Employee Stock Option (Right to Buy) | D | 3,26 | 25 000 | 25 000 | |||||
2016-05-16 | 2016-05-12 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2899 | 4 170 | 14 | 19 800 | ||||
2016-05-16 | 2016-05-12 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2897 | 530 | 2 | 15 630 | ||||
2016-05-16 | 2016-05-12 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2399 | 300 | 1 | 15 100 | ||||
2016-04-18 | 2016-04-14 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | 265 000 | 265 000 | |||||
2016-02-05 | 2016-02-03 | 4 | LANGER DENNIS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −34 722 | 6 945 | |||||
2016-02-05 | 2016-02-03 | 4 | LANGER DENNIS | DRNA | Common Stock | D | 3,4200 | 34 722 | 119 | 43 595 | ||||
2016-01-12 | 2016-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 225 000 | 225 000 | |||||
2016-01-12 | 2016-01-08 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | −75 000 | 75 000 | |||||
2016-01-12 | 2016-01-08 | 4 | Bhargava Pankaj | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 75 000 | 75 000 | |||||
2016-01-12 | 2016-01-08 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 75 000 | 75 000 | |||||
2016-01-12 | 2016-01-08 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 125 000 | 125 000 | |||||
2015-06-29 | 2015-06-25 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 13,87 | 15 000 | 15 000 | |||||
2015-06-29 | 2015-06-25 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15 000 | 15 000 | |||||
2015-06-29 | 2015-06-25 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15 000 | 15 000 | |||||
2015-06-26 | 2015-06-25 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15 000 | 15 000 | |||||
2015-06-26 | 2015-06-25 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 13,87 | 20 000 | 20 000 | |||||
2015-06-26 | 2015-06-25 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15 000 | 15 000 | |||||
2015-02-24 | 2015-02-20 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 26,0200 | −37 532 | −977 | 1 719 671 | ||||
2015-01-13 | 2015-01-09 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 75 000 | 75 000 | |||||
2015-01-13 | 2015-01-09 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 225 000 | 225 000 | |||||
2015-01-13 | 2015-01-09 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 3 333 | 3 333 | |||||
2015-01-13 | 2015-01-09 | 4 | Dentzer James E | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 75 000 | 75 000 | |||||
2015-01-13 | 2015-01-09 | 4 | Bhargava Pankaj | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 56 250 | 56 250 | |||||
2015-01-13 | 2015-01-09 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 75 000 | 75 000 | |||||
2014-12-19 | 2014-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −1 450 | 0 | |||||
2014-12-19 | 2014-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | −1 050 | 0 | |||||
2014-12-19 | 2014-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 2 500 | 9 | 19 800 | ||||
2014-12-16 | 2014-12-15 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 13,08 | 115 000 | 115 000 | |||||
2014-12-16 | 2014-12-15 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 13,08 | 115 000 | 115 000 | |||||
2014-12-16 | 3 | Ashburn Theodore | DRNA | No securities are beneficially owned | D | 0 | ||||||||
2014-12-11 | 2014-12-09 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 11,04 | 25 000 | 25 000 | |||||
2014-11-25 | 2014-11-25 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,5000 | −55 035 | −633 | 800 794 | ||||
2014-11-25 | 2014-11-25 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,5000 | −48 027 | −552 | 698 822 | ||||
2014-11-25 | 2014-11-25 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,5000 | −18 903 | −217 | 275 046 | ||||
2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,5400 | −3 785 | −44 | 855 829 | ||||
2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,5400 | −3 303 | −38 | 746 849 | ||||
2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,5500 | −14 199 | −164 | 293 949 | ||||
2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,5500 | −41 339 | −477 | 859 614 | ||||
2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,5500 | −36 074 | −417 | 750 152 | ||||
2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,5400 | −1 300 | −15 | 308 148 | ||||
2014-11-25 | 2014-11-21 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,0000 | −45 124 | −496 | 900 953 | ||||
2014-11-25 | 2014-11-21 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,0000 | −39 377 | −433 | 786 226 | ||||
2014-11-25 | 2014-11-21 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,0000 | −15 499 | −170 | 309 448 | ||||
2014-11-10 | 2014-11-07 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 9,3300 | −30 100 | −281 | 0 | ||||
2014-11-10 | 2014-11-07 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 9,2700 | −3 500 | −32 | 30 100 | ||||
2014-11-10 | 2014-11-07 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 9,0000 | −180 564 | −1 625 | 33 600 | ||||
2014-10-15 | 2014-10-15 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 10,0100 | −51 449 | −515 | 214 164 | ||||
2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,0200 | −14 464 | −159 | 946 077 | ||||
2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,0200 | −12 622 | −139 | 825 603 | ||||
2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 11,0200 | −4 061 | −45 | 265 613 | ||||
2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,0200 | −4 968 | −55 | 324 947 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 12,0020 | −246 | −3 | 960 541 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 12,0020 | −215 | −3 | 838 225 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 12,0020 | −69 | −1 | 269 674 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 12,0020 | −84 | −1 | 330 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 12,1350 | −11 855 | −144 | 960 787 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 12,1350 | −10 345 | −126 | 838 440 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 12,1350 | −3 328 | −40 | 269 743 | ||||
2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 12,1350 | −4 072 | −49 | 329 999 | ||||
2014-06-24 | 2014-06-18 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15 000 | 15 000 | |||||
2014-06-23 | 2014-06-18 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15 000 | 15 000 | |||||
2014-06-23 | 2014-06-18 | 4 | Miles Vincent J | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15 000 | 15 000 | |||||
2014-06-20 | 2014-06-18 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 18,73 | 15 000 | 15 000 | |||||
2014-06-20 | 2014-06-18 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 18,73 | 20 000 | 20 000 | |||||
2014-06-20 | 2014-06-18 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15 000 | 15 000 | |||||
2014-05-08 | 2014-04-16 | 4/A | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 16,30 | 25 000 | 25 000 | |||||
2014-04-30 | 2014-04-16 | 4/A | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 16,30 | 25 000 | 25 000 | |||||
2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Series C Preferred | I | −71 428 | 0 | ||||||
2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Series B Preferred | I | −8 586 | 0 | ||||||
2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Series A Preferred | I | −15 000 | 0 | ||||||
2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 95 014 | 95 194 | ||||||
2014-04-21 | 2014-04-16 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | DRNA | Director Stock Option (right to buy) | I | 16,30 | 25 000 | 25 000 | |||||
2014-04-18 | 2014-04-16 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 16,30 | 25 000 | 25 000 | |||||
2014-04-18 | 2014-04-16 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 16,30 | 25 000 | 25 000 | |||||
2014-04-18 | 2014-04-16 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 16,30 | 25 000 | 25 000 | |||||
2014-04-18 | 2014-04-16 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 471 900 | 471 900 | |||||
2014-04-18 | 2014-04-16 | 4 | Miles Vincent J See footnotes | DRNA | Director Stock Option (right to buy | I | 16,30 | 25 000 | 25 000 | |||||
2014-04-18 | 2014-04-16 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 16,30 | 30 000 | 30 000 | |||||
2014-04-18 | 2014-04-16 | 4 | Dentzer James E | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 108 750 | 108 750 | |||||
2014-04-18 | 2014-04-16 | 4 | Brown Bob D | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 165 050 | 165 050 | |||||
2014-04-18 | 2014-04-16 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 111 800 | 111 800 | |||||
2014-04-18 | 2014-04-16 | 4 | Bhargava Pankaj | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 264 808 | 264 808 | |||||
2014-04-11 | 2014-03-18 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 38,6200 | −14 937 | −577 | 1 550 862 | ||||
2014-04-11 | 2014-03-18 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 37,7500 | −250 000 | −9 438 | 1 565 799 | ||||
2014-04-11 | 2014-03-17 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 36,5000 | −9 301 | −339 | 1 815 799 | ||||
2014-04-11 | 2014-03-14 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 35,5000 | −200 000 | −7 100 | 1 825 100 | ||||
2014-04-11 | 2014-03-14 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 35,3300 | −50 400 | −1 781 | 2 025 100 | ||||
2014-04-11 | 2014-03-12 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 37,7700 | −1 500 | −57 | 2 075 500 | ||||
2014-04-11 | 2014-03-11 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 38,3700 | −2 900 | −111 | 2 077 000 | ||||
2014-04-11 | 2014-03-11 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 38,0000 | −257 100 | −9 770 | 2 079 900 | ||||
2014-04-03 | 3 | Bhargava Pankaj | DRNA | No securities are beneficially owned | D | 0 | ||||||||
2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series C Preferred | I | −71 428 | 0 | ||||||
2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series B Preferred | I | −8 586 | 0 | ||||||
2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series A Preferred | I | −10 000 | 0 | ||||||
2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Common Stock | I | 90 014 | 90 014 | ||||||
2014-02-20 | 2014-01-27 | 4/A | LANGER DENNIS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −540 | 0 | |||||
2014-02-20 | 2014-01-27 | 4/A | LANGER DENNIS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −8 333 | 41 667 | |||||
2014-02-20 | 2014-01-27 | 4/A | LANGER DENNIS | DRNA | Common Stock | D | 3,4200 | 8 873 | 30 | 8 873 | ||||
2014-02-20 | 2013-09-24 | 4/A | LANGER DENNIS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 50 000 | 50 000 | |||||
2014-02-20 | 2014-01-29 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 15,0000 | 5 000 | 75 | 17 300 | ||||
2014-02-20 | 2013-11-11 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −4 350 | 1 450 | |||||
2014-02-20 | 2013-11-11 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −4 950 | 1 050 | |||||
2014-02-20 | 2013-11-11 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 9 300 | 32 | 12 300 | ||||
2014-02-20 | 2013-09-24 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 281 250 | 281 250 | |||||
2014-02-20 | 2013-09-24 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 281 250 | 281 250 | |||||
2014-02-20 | 2014-01-29 | 4 | MADDEN DAVID | DRNA | Common Stock | D | 15,0000 | 7 500 | 112 | 120 011 | ||||
2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −110 000 | 0 | |||||
2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −1 311 | 0 | |||||
2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −1 200 | 0 | |||||
2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Common Stock | D | 3,4200 | 112 511 | 385 | 112 511 | ||||
2014-02-20 | 2013-09-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 110 000 | 110 000 | |||||
2014-02-20 | 2014-01-29 | 4 | Weissman James B | DRNA | Common Stock | D | 15,0000 | 1 000 | 15 | 13 116 | ||||
2014-02-20 | 2014-01-27 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −67 | 800 | |||||
2014-02-20 | 2014-01-27 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −11 216 | 78 784 | |||||
2014-02-20 | 2014-01-27 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2400 | 11 283 | 37 | 12 116 | ||||
2014-02-20 | 2013-11-11 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −100 | 1 500 | |||||
2014-02-20 | 2013-11-11 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | −733 | 867 | |||||
2014-02-20 | 2013-11-05 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 833 | 3 | 833 | ||||
2014-02-20 | 2013-09-24 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 90 000 | 90 000 | |||||
2014-02-20 | 2013-09-24 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 60 000 | 60 000 | |||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock Warrant (right to buy) | I | 7,00 | 21 697 | 21 697 | |||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series C Preferred Stock Warrants | I | 7,00 | −21 697 | 0 | |||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock Warrant | I | 250,00 | 755 | 755 | |||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series C Preferred Stock | I | −1 043 429 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series B Preferred Stock | I | −179 322 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series A Preferred Stock | I | −312 000 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 15,0000 | 200 000 | 3 000 | 1 734 751 | ||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 1 043 429 | 1 534 751 | ||||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 179 322 | 491 322 | ||||||
2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 312 000 | 312 000 | ||||||
2014-02-05 | 2014-02-04 | 4 | RA CAPITAL MANAGEMENT, LLC | DRNA | Series C Preferred Stock, par value $0.0001 | D | −1 428 571 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | DRNA | Common Stock, par value $0.0001 per share | I | 15,0000 | 1 000 000 | 15 000 | 2 428 571 | ||||
2014-02-05 | 2014-02-04 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | DRNA | Common Stock, par value $0.0001 per share | I | 1 428 571 | 1 428 571 | ||||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock Warrant (right to buy) | I | 7,00 | 21 697 | 21 697 | |||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series C Preferred Stock Warrants | I | 7,00 | −21 697 | 0 | |||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock Warrant | I | 250,00 | 755 | 755 | |||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series C Preferred Stock | I | −1 043 429 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series B Preferred Stock | I | −179 322 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series A Preferred Stock | I | −312 000 | 0 | ||||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 15,0000 | 200 000 | 3 000 | 1 734 751 | ||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 1 043 429 | 1 534 751 | ||||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 179 322 | 491 322 | ||||||
2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 312 000 | 312 000 | ||||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series C Preferred | I | −71 428 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series B Preferred | I | −8 586 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series A Preferred | I | −10 000 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Common Stock | I | 90 014 | 90 194 | ||||||
2014-02-04 | 3 | Brookside Capital Trading Fund, L.P. | DRNA | Common Stock | I | 2 337 000 | ||||||||
2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Warrant | D | 7,00 | 156 | 156 | |||||
2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Warrant | D | 7,00 | −156 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | D | −9 469 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | D | −3 535 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Common Stock | D | 13 004 | 13 004 | ||||||
2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Warrant | D | 7,00 | 21 041 | 21 041 | |||||
2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Warrant | D | 7,00 | −21 041 | 0 | |||||
2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | D | −1 276 243 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | D | −476 464 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Common Stock | D | 1 752 707 | 1 752 707 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Series C Preferred Stock | I | −572 142 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Series C Preferred Stock | I | −499 285 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Series C Preferred Stock | I | −161 071 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Series C Preferred Stock | I | −196 071 | 0 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 15,0000 | 400 500 | 6 008 | 972 642 | ||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 15,0000 | 349 500 | 5 242 | 848 785 | ||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 15,0000 | 112 000 | 1 680 | 273 071 | ||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 15,0000 | 138 000 | 2 070 | 334 071 | ||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 572 142 | 972 642 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 499 285 | 848 785 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 161 071 | 273 071 | ||||||
2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 196 071 | 334 071 | ||||||
2014-01-29 | 3 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 12 300 | ||||||||
2014-01-29 | 3 | MADDEN DAVID | DRNA | Common Stock | D | 112 511 | ||||||||
2014-01-29 | 3 | LANGER DENNIS | DRNA | Common Stock | D | 8 873 | ||||||||
2014-01-29 | 3 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Common Stock | I | 180 | ||||||||
2014-01-29 | 3 | Miles Vincent J | DRNA | No securities are beneficially owned | D | 0 | ||||||||
2014-01-29 | 3 | Brown Bob D | DRNA | Common Stock | D | 19 339 | ||||||||
2014-01-29 | 3 | Weissman James B | DRNA | Common Stock | D | 12 116 |